Epigallocatechin gallate ameliorates behavioral and biochemical deficits in rat model of load-induced chronic fatigue syndrome

Brain Research Bulletin

Volumn 86, Issue 3-4, 2011, Pages 165-172

  Sachdeva, Anand Kamal ^a   Kuhad, Anurag ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Chronic fatigue syndrome; Epigallocatechin gallate; Forced swimming test; Load; Tumor necrosis factor

Indexed keywords

EPIGALLOCATECHIN GALLATE; MALONALDEHYDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BODY WEIGHT; BRAIN; CHRONIC FATIGUE SYNDROME; COGNITION; CONTROLLED STUDY; ENDURANCE; FORCED SWIMMING TEST; GRIP STRENGTH; HYPERALGESIA; LOCOMOTION; MALE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPLEEN; SPLEEN WEIGHT; THYMUS; WEIGHT BEARING;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN CHEMISTRY; CATECHIN; COGNITION; DRINKING; EATING; FATIGUE SYNDROME, CHRONIC; HYPERALGESIA; MALE; MAZE LEARNING; MOTOR ACTIVITY; NITRIC OXIDE; ORGAN SIZE; OXIDATIVE STRESS; PHYSICAL ENDURANCE; POSTURAL BALANCE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053239592     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.06.007     Document Type: Article

References (66)

1. Akula K.K., Dhir A., Bishnoi M., Kulkarni S.K. Effect of systemic administration of adenosine on brain adenosine levels in pentylenetetrazol-induced seizure threshold in mice. Neurosci. Lett. 2007, 425:39-42.
2. Askew E.W. Work at high altitude and oxidative stress: antioxidant nutrients. Toxicology 2002, 180:107-119.
3. Atamaniuk J., Vidotto C., Tschan H., Bachl N., Stuhlmeier K.M., Muller M.M. Increased concentrations of cell-free plasma DNA after exhaustive exercise. Clin. Chem. 2004, 50:1668-1670.
4. Blanco A.R., Sudano-Roccaro A., Spoto G.C., Nostro A., Rusciano D. Epigallocatechin gallate inhibits biofilm formation by ocular staphylococcal isolates. Antimicrob. Agents Chemother. 2005, 49:4339-4343.
5. Cabib S., Zocchi A., Puglisi-Allegra S. A comparison of the behavioral effects of minaprine, amphetamine and stress. Psychopharmacology (Berl.) 1995, 121:73-80.
6. Chao C.C, DeLaHunt M., Hu S., Close K., Peterson P.K. Immunologically mediated fatigue: a murine model. Clin. Immunol. Immunopathol. 1992, 64:161-165.
7. Checkley S. Neuroendocrine mechanisms and the precipitation of depression by life events. Br. J. Psychiatry 1992, 15(Suppl.):7-17.
8. Chen J.H., Tipoe G.L., Liong E.C., So H.S.H., Leung K.M., Tom W.M., Fung P.C.W., Nanji A.A. Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am. J. Clin. Nutr. 2004, 80:742-751.
9. Chen R., Moriya J., Yamakawa J., Takahashi T., Li Q., Morimoto S., Iwai K., Sumino H., Yamaguchi N., Kanda T. Brain atrophy in a murine model of chronic fatigue syndrome and beneficial effect of Hochu-ekki-to (TJ-41). Neurochem. Res. 2008, 33:1759-1767.
10. Choi Y.B., Kim Y.I., Lee K.S., Kim B.S., Kim D.J. Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats. Brain Res. 2004, 1019:47-54.
11. Claiborne A. Catalase activity. CRC Handbook of Methods for Oxygen Radical Research 1985, 283-284. CRC Press, Boca Raton, FL. R.A. Greenwald (Ed.).
12. Dawson C.A., Nadel E.R., Horvath S.M. Cardiac output in the cold-stressed swimming rat. Am. J. Physiol. 1968, 214:320-325.
13. Dhir A., Kulkarni S.K. Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice. Pharmacol. Biochem. Behav. 2008, 89:563-571.
14. Fantino M., Wieteska L. Evidence for a direct central anorectic effect of tumor-necrosis-factor-alpha in the rat. Physiol. Behav. 1993, 53:477-483.
15. Finsterer J. Mitochondriopathies. Eur. J. Neurol. 2004, 11:163-186.
16. Goebel M.U., Mills P.J., Irwin M.R., Ziegler M.G. Interleukin-6 and tumor necrosis factor-α production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways. Psychosom. Med. 2000, 62:591-598.
17. Guo Q., Zhao B., Li M., Shen S., Xin W. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim. Biophys. Acta 1996, 1304:210-222.
18. Hernaez J.F., Xu M., Dashwood R.H. Antimutagenic activity of tea towards 2-hydroxyamino-3-methylimidazo [4,5-f] quinoline: effect of tea concentration and brew time on electrophile scavenging. Mutat. Res. 1998, 402:299-306.
19. Ito M., Nishiyama K., Hyodo S., Shigeta S., Ito T. Weight reduction of thymus and depletion of lymphocytes of T-dependent areas in peripheral lymphoid tissues of mice infected with Francisella tularensis. Infect. Immun. 1985, 49:812-818.
20. Jammes Y., Steinberg J.G., Mambrini O., Bregeon F., Delliaux S. Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. J. Intern. Med. 2005, 257:299-310.
21. Jollow D.J., Mitchell J.R., Zampaglione N., Gillette J.R. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974, 11:151-169.
22. Kalenova L.F., Sukhovei Y.G., Fisher T.A. Specific and nonspecific reactions of mouse immune system under the effect of short-term exposure in warm and/or cold water. Bull. Exp. Biol. Med. 2005, 140:720-722.
23. Kang W.S., Lim I.H., Yuk D.Y., Chung K.H., Park J.B., Yoo H.S., Yun Y.P. Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb. Res. 1999, 96:229-237.
24. Katon W., Walker E.A. The Relationship of Chronic Fatigue to Psychiatric Illness in Community, Primary Care and Tertiary Care Samples 1993, John Wiley & Sons Ltd., pp. 193-211.
25. Khalatbary A.R., Tiraihi T., Boroujeni M.B., Ahmadvand H., Tavafi M., Tamjidipoor A. Effects of epigallocatechin gallate on tissue protection and functional recovery after contusive spinal cord injury in rats. Brain Res. 2010, 1306:168-175.
26. Koh S.H., Lee S.M., Kim H.Y., Lee K.Y., Lee Y.J., Kim H.T., Kim J., Kim M.H., Hwang M.S., Song C., Yang K.W., Lee K.W., Kim S.H., Kim O.H. The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neurosci. Lett. 2006, 395:103-107.
27. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys. 1978, 186:189-195.
28. Krupp L.B., Pollina D.A. Mechanisms and management of fatigue in progressive neurological disorders. Curr. Opin. Neurol. 1996, 9:456-460.
29. Kuo Y.H., Tsai W.J., Loke S.H., Wu T.S., Chiou W.F. Astragalus membranaceus flavonoids (AMF) ameliorate chronic fatigue syndrome induced by food intake restriction plus forced swimming. J. Ethnopharmacol. 2009, 122:28-34.
30. Leocani L., Colombo B., Comi G. Physiopathology of fatigue in multiple sclerosis. Neurol. Sci. 2008, 29:241-243.
31. Lin Y.L., Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Mol. Pharmacol. 1997, 52:465-472.
32. Logan A.C., Wong C. Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern. Med. Rev. 2001, 6:450-459.
33. Lorenz M., Wessler S., Follmann E., Michaelis W., Düsterhöft T., Baumann G., Stangl K., Stangl V. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J. Biol. Chem. 2004, 279:6190-6195.
34. Lutgendorf S.K., Antoni M.H., Ironson G., Fletcher M.A., Penedo F., Baum A., Schneiderman N., Klimas N. Physical symptoms of chronic fatigue syndrome are exacerbated by the stress of Hurricane Andrew. Psychosom. Med. 1995, 57:310-323.
35. Lyu S.Y., Rhim J.Y., Park W.B. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch. Pharm. Res. 2005, 28:1293-1301.
36. McDonald E., Cope H., David A. Cognitive impairment in patients with chronic fatigue: a preliminary study. Neurol. Neurosurg. Psychiatry 1993, 56:812-815.
37. McEwen B.S., Sapolsky R.M. Stress and cognitive function. Curr. Opin. Neurobiol. 1995, 5:205-216.
38. Moss R.B., Mercandetti A., Vojdani A. TNF-α and chronic fatigue syndrome. J. Clin. Immunol. 1999, 314-316.
39. Powers S.K., Deruisseau K.C., Quindry J., Hamilton K.L. Dietary antioxidants and exercise. J. Sports Sci. 2004, 22:81-94.
40. Quintero L., Moreno M., Avila C., Arcaya J., Maixner W., Suarez-Roca H. Long-lasting delayed hyperalgesia after subchronic swim stress. Pharmacol. Biochem. Behav. 2000, 67:449-458.
41. Reddy D.S., Kulkarni S.K. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment. Brain Res. 1998, 799:215-229.
42. Reznichenko L., Amit T., Youdim M.B.H., Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth. J. Neurochem. 2005, 93:1157-1167.
43. Roelcke U., Kappos L., Lechner-Scott J., Brunnschweiler H., Huber S., Ammann W., Plohmann A., Dellas S., Maguire R.P., Missimer J. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology 1997, 48:1566-1571.
44. Roy-Byrne P., Afari N., Ashton S., Fischer M., Goldberg J., Buchwald D. Chronic fatigue and anxiety/depression: a twin study. Br. J. Psychiatry 2002, 180:29-34.
45. Sachdeva A.K., Kuhad A., Tiwari V., Arora V., Chopra K. Protective effect of epigallocatechin gallate in murine water-immersion stress model of chronic fatigue syndrome. Basic Clin. Pharmacol. Toxicol. 2010, 106:490-496.
46. Sachdeva A.K., Kuhad A., Tiwari V., Chopra K. Epigallocatechin gallate ameliorates chronic fatigue syndrome in mice: behavioral and biochemical evidence. Behav. Brain Res. 2009, 205:414-420.
47. Sapolsky R.M. Why stress is bad for your brain. Science 1996, 273:749-750.
48. Schmaling K.B., Fiedelak J.I., Katon W.J., Bader J.O., Buchwald D.S. Prospective study of the prognosis of unexplained chronic fatigue in a clinic-based cohort. Psychosom. Med. 2003, 65:1047-1054.
49. Schulte-Mattler W.J., Muller T., Deschauer M., Gellerich F.N., Iaizzo P.A., Zierz S. Increased metabolic muscle fatigue is caused by some but not all mitochondrial mutations. Arch. Neurol. 2003, 60:50-58.
50. Singh A., Kulkarni S.K. Role of adenosine in drug-induced catatonia in mice. Indian J. Exp. Biol. 2002, 40:882-888.
51. Singh A., Naidu P.S., Gupta S., Kulkarni S.K. Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J. Med. Food 2002, 5:211-220.
52. Skrzydlewska E., Ostrowska J., Farbiszewski R., Michalak K. Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain. Phytomedicine 2002, 9:232-238.
53. Song J.M., Lee K.H., Seong B.L. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005, 68:66-74.
54. Steptoe A., Willemsen G., Owen N., Flower L., Mohamed-Ali V. Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clin. Sci. 2001, 101:185-192.
55. Strekalova T., Spanagel R., Dolgov O., Bartsch D. Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice. Behav. Pharmacol. 2005, 16:171-180.
56. Sutherland B.A., Rahman R., Appleton I. Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. J. Nutr. Biochem. 2006, 17:291-306.
57. Tanaka M., Nakamura F., Mizokawa S., Matsumura A., Nozaki S., Watanabe Y. Establishment and assessment of a rat model of fatigue. Neurosci. Lett. 2003, 352:159-162.
58. Tanriverdi F., Karaca Z., Unluhizarci K., Kelestimur F. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress 2007, 10:13-25.
59. Tedeschi E., Suzuki H., Menegazzi M. Antiinflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition. Ann. N. Y. Acad. Sci. 2002, 973:435-437.
60. Tirelli U., Chierichetti F., Tavio M., Simonelli C., Bianchin G., Zanco P., Ferlin G. Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am. J. Med. 1998, 105:54-58.
61. Tiwari V., Kuhad A., Chopra K. Tocotrienol ameliorates behavioral and biochemical alterations in the rat model of alcoholic neuropathy. Pain 2009, 145:129-135.
62. Wearden A.J., Appleby L. Research on cognitive complaints and cognitive functioning in patients with chronic fatigue syndrome (CFS): what conclusions can we draw?. J. Psychosom. Res. 1996, 41:197-211.
63. Wills E.D. Mechanism of lipid peroxide formation in animal tissues. Biochem. J. 1966, 99:667-676.
64. Yamamoto Y., Matsunaga K., Friedman H. Protective effects of green tea catechins on alveolar macrophages against bacterial infections. Biofactors 2004, 21:119-121.
65. Yoshino K., Ogawa K., Miyase T., Sano M. Inhibitory effects of the C-2 epimeric isomers of tea catechins on mouse type IV allergy. J. Agric. Food Chem. 2004, 52:4660-4663.
66. Zhang B., Rusciano D., Osborne N.N. Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro. Brain Res. 2008, 1198:141-152.